Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
Merck
Colorcon
Daiichi Sankyo
Cipla
Mallinckrodt
Accenture
Fuji
Chinese Patent Office

Generated: January 24, 2018

DrugPatentWatch Database Preview

MUTAMYCIN Drug Profile

« Back to Dashboard

Which patents cover Mutamycin, and when can generic versions of Mutamycin launch?

Mutamycin is a drug marketed by Bristol and Bristol Myers and is included in two NDAs.

The generic ingredient in MUTAMYCIN is mitomycin. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mitomycin profile page.

US Patents and Regulatory Information for MUTAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol MUTAMYCIN mitomycin INJECTABLE;INJECTION 050450-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers MUTAMYCIN mitomycin INJECTABLE;INJECTION 062336-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol MUTAMYCIN mitomycin INJECTABLE;INJECTION 050450-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers MUTAMYCIN mitomycin INJECTABLE;INJECTION 062336-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers MUTAMYCIN mitomycin INJECTABLE;INJECTION 062336-003 Mar 10, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Mallinckrodt
Deloitte
Covington
Cerilliant
Cipla
Healthtrust
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot